nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—Localised skin reaction—Capecitabine—stomach cancer	0.0742	0.084	CcSEcCtD
Latanoprost—Skin reaction—Capecitabine—stomach cancer	0.0742	0.084	CcSEcCtD
Latanoprost—Cystoid macular oedema—Docetaxel—stomach cancer	0.044	0.0498	CcSEcCtD
Latanoprost—Embolism—Floxuridine—stomach cancer	0.0305	0.0346	CcSEcCtD
Latanoprost—Lacrimation increased—Floxuridine—stomach cancer	0.0213	0.0241	CcSEcCtD
Latanoprost—Scab—Fluorouracil—stomach cancer	0.0201	0.0228	CcSEcCtD
Latanoprost—Bimatoprost—AKR1C3—stomach cancer	0.02	0.794	CrCbGaD
Latanoprost—Stinging—Mitomycin—stomach cancer	0.019	0.0215	CcSEcCtD
Latanoprost—Photophobia—Floxuridine—stomach cancer	0.0184	0.0208	CcSEcCtD
Latanoprost—Scab—Capecitabine—stomach cancer	0.0141	0.0159	CcSEcCtD
Latanoprost—Angina pectoris—Floxuridine—stomach cancer	0.012	0.0136	CcSEcCtD
Latanoprost—Embolism—Irinotecan—stomach cancer	0.0104	0.0118	CcSEcCtD
Latanoprost—Blepharitis—Fluorouracil—stomach cancer	0.0104	0.0118	CcSEcCtD
Latanoprost—Erythema—Floxuridine—stomach cancer	0.00857	0.0097	CcSEcCtD
Latanoprost—Stinging—Fluorouracil—stomach cancer	0.0079	0.00894	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA5—stomach cancer	0.00757	0.0831	CbGpPWpGaD
Latanoprost—Eye irritation—Fluorouracil—stomach cancer	0.00749	0.00848	CcSEcCtD
Latanoprost—Lacrimation increased—Irinotecan—stomach cancer	0.00725	0.0082	CcSEcCtD
Latanoprost—Discomfort—Floxuridine—stomach cancer	0.00721	0.00816	CcSEcCtD
Latanoprost—Embolism—Docetaxel—stomach cancer	0.00719	0.00814	CcSEcCtD
Latanoprost—Embolism—Capecitabine—stomach cancer	0.00697	0.00788	CcSEcCtD
Latanoprost—Lacrimation increased—Fluorouracil—stomach cancer	0.00694	0.00786	CcSEcCtD
Latanoprost—Keratitis—Capecitabine—stomach cancer	0.00689	0.0078	CcSEcCtD
Latanoprost—Nervous system disorder—Floxuridine—stomach cancer	0.00686	0.00776	CcSEcCtD
Latanoprost—Erythema—Mitomycin—stomach cancer	0.00673	0.00761	CcSEcCtD
Latanoprost—Inflammation—Fluorouracil—stomach cancer	0.0066	0.00746	CcSEcCtD
Latanoprost—Vision blurred—Mitomycin—stomach cancer	0.00634	0.00717	CcSEcCtD
Latanoprost—Dermatitis atopic—Docetaxel—stomach cancer	0.00624	0.00706	CcSEcCtD
Latanoprost—Photophobia—Fluorouracil—stomach cancer	0.00601	0.0068	CcSEcCtD
Latanoprost—Discomfort—Mitomycin—stomach cancer	0.00566	0.0064	CcSEcCtD
Latanoprost—Oedema—Mitomycin—stomach cancer	0.00549	0.00621	CcSEcCtD
Latanoprost—Eye irritation—Docetaxel—stomach cancer	0.00541	0.00612	CcSEcCtD
Latanoprost—Eye irritation—Capecitabine—stomach cancer	0.00524	0.00593	CcSEcCtD
Latanoprost—Embolism—Methotrexate—stomach cancer	0.00519	0.00587	CcSEcCtD
Latanoprost—Tafluprost—PTGS2—stomach cancer	0.00518	0.206	CrCbGaD
Latanoprost—Lacrimation increased—Docetaxel—stomach cancer	0.00501	0.00567	CcSEcCtD
Latanoprost—Dyspnoea—Mitomycin—stomach cancer	0.00489	0.00554	CcSEcCtD
Latanoprost—Embolism—Epirubicin—stomach cancer	0.00485	0.00549	CcSEcCtD
Latanoprost—Lacrimation increased—Capecitabine—stomach cancer	0.00485	0.00549	CcSEcCtD
Latanoprost—Keratitis—Epirubicin—stomach cancer	0.0048	0.00543	CcSEcCtD
Latanoprost—Inflammation—Docetaxel—stomach cancer	0.00476	0.00539	CcSEcCtD
Latanoprost—Pain—Mitomycin—stomach cancer	0.00469	0.00531	CcSEcCtD
Latanoprost—Inflammation—Capecitabine—stomach cancer	0.00461	0.00522	CcSEcCtD
Latanoprost—Embolism—Doxorubicin—stomach cancer	0.00449	0.00508	CcSEcCtD
Latanoprost—Keratitis—Doxorubicin—stomach cancer	0.00444	0.00503	CcSEcCtD
Latanoprost—Rash—Floxuridine—stomach cancer	0.00441	0.00499	CcSEcCtD
Latanoprost—Dermatitis—Floxuridine—stomach cancer	0.00441	0.00499	CcSEcCtD
Latanoprost—Headache—Floxuridine—stomach cancer	0.00438	0.00496	CcSEcCtD
Latanoprost—Dermatitis atopic—Epirubicin—stomach cancer	0.00421	0.00476	CcSEcCtD
Latanoprost—Dry eye—Capecitabine—stomach cancer	0.00413	0.00467	CcSEcCtD
Latanoprost—Angina pectoris—Irinotecan—stomach cancer	0.00408	0.00462	CcSEcCtD
Latanoprost—Angina pectoris—Fluorouracil—stomach cancer	0.00391	0.00442	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—ANXA1—stomach cancer	0.0039	0.0428	CbGpPWpGaD
Latanoprost—Upper respiratory tract infection—Irinotecan—stomach cancer	0.0039	0.00441	CcSEcCtD
Latanoprost—Dermatitis atopic—Doxorubicin—stomach cancer	0.00389	0.00441	CcSEcCtD
Latanoprost—Stinging—Epirubicin—stomach cancer	0.00385	0.00435	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Fluorouracil—stomach cancer	0.00373	0.00422	CcSEcCtD
Latanoprost—Hepatic function abnormal—Capecitabine—stomach cancer	0.00371	0.0042	CcSEcCtD
Latanoprost—Dizziness—Mitomycin—stomach cancer	0.00363	0.00411	CcSEcCtD
Latanoprost—Eye pain—Capecitabine—stomach cancer	0.0036	0.00407	CcSEcCtD
Latanoprost—Stinging—Doxorubicin—stomach cancer	0.00356	0.00403	CcSEcCtD
Latanoprost—Urinary tract infection—Fluorouracil—stomach cancer	0.00348	0.00394	CcSEcCtD
Latanoprost—Conjunctivitis—Fluorouracil—stomach cancer	0.00348	0.00394	CcSEcCtD
Latanoprost—Rash—Mitomycin—stomach cancer	0.00346	0.00392	CcSEcCtD
Latanoprost—Dermatitis—Mitomycin—stomach cancer	0.00346	0.00391	CcSEcCtD
Latanoprost—Headache—Mitomycin—stomach cancer	0.00344	0.00389	CcSEcCtD
Latanoprost—Inflammation—Methotrexate—stomach cancer	0.00343	0.00388	CcSEcCtD
Latanoprost—SLCO2B1—Transport of organic anions—ALB—stomach cancer	0.00342	0.0376	CbGpPWpGaD
Latanoprost—Lacrimation increased—Epirubicin—stomach cancer	0.00338	0.00382	CcSEcCtD
Latanoprost—Connective tissue disorder—Irinotecan—stomach cancer	0.0033	0.00373	CcSEcCtD
Latanoprost—Diplopia—Capecitabine—stomach cancer	0.00325	0.00367	CcSEcCtD
Latanoprost—Inflammation—Epirubicin—stomach cancer	0.00321	0.00363	CcSEcCtD
Latanoprost—Lacrimation increased—Doxorubicin—stomach cancer	0.00313	0.00354	CcSEcCtD
Latanoprost—Mediastinal disorder—Irinotecan—stomach cancer	0.00302	0.00342	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.00302	0.00342	CcSEcCtD
Latanoprost—Inflammation—Doxorubicin—stomach cancer	0.00297	0.00336	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Other—HRH4—stomach cancer	0.00297	0.0326	CbGpPWpGaD
Latanoprost—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.00292	0.00331	CcSEcCtD
Latanoprost—SLCO2B1—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.00288	0.0317	CbGpPWpGaD
Latanoprost—Dry eye—Epirubicin—stomach cancer	0.00288	0.00326	CcSEcCtD
Latanoprost—Back pain—Irinotecan—stomach cancer	0.00283	0.0032	CcSEcCtD
Latanoprost—Angina pectoris—Docetaxel—stomach cancer	0.00282	0.00319	CcSEcCtD
Latanoprost—Asthma—Capecitabine—stomach cancer	0.00281	0.00317	CcSEcCtD
Latanoprost—Erythema—Fluorouracil—stomach cancer	0.0028	0.00317	CcSEcCtD
Latanoprost—Angina pectoris—Capecitabine—stomach cancer	0.00273	0.00309	CcSEcCtD
Latanoprost—Bronchitis—Capecitabine—stomach cancer	0.0027	0.00305	CcSEcCtD
Latanoprost—Dry eye—Doxorubicin—stomach cancer	0.00266	0.00301	CcSEcCtD
Latanoprost—Vision blurred—Fluorouracil—stomach cancer	0.00264	0.00298	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Capecitabine—stomach cancer	0.00261	0.00295	CcSEcCtD
Latanoprost—Hepatic function abnormal—Epirubicin—stomach cancer	0.00259	0.00293	CcSEcCtD
Latanoprost—Eczema—Epirubicin—stomach cancer	0.00252	0.00285	CcSEcCtD
Latanoprost—Conjunctivitis—Docetaxel—stomach cancer	0.00251	0.00284	CcSEcCtD
Latanoprost—Eye pain—Epirubicin—stomach cancer	0.0025	0.00283	CcSEcCtD
Latanoprost—Discomfort—Irinotecan—stomach cancer	0.00246	0.00278	CcSEcCtD
Latanoprost—Conjunctivitis—Capecitabine—stomach cancer	0.00243	0.00275	CcSEcCtD
Latanoprost—Urinary tract infection—Capecitabine—stomach cancer	0.00243	0.00275	CcSEcCtD
Latanoprost—Hepatic function abnormal—Doxorubicin—stomach cancer	0.00239	0.00271	CcSEcCtD
Latanoprost—Oedema—Irinotecan—stomach cancer	0.00238	0.0027	CcSEcCtD
Latanoprost—Chest pain—Fluorouracil—stomach cancer	0.00238	0.00269	CcSEcCtD
Latanoprost—Discomfort—Fluorouracil—stomach cancer	0.00235	0.00266	CcSEcCtD
Latanoprost—Nervous system disorder—Irinotecan—stomach cancer	0.00234	0.00265	CcSEcCtD
Latanoprost—Eczema—Doxorubicin—stomach cancer	0.00233	0.00263	CcSEcCtD
Latanoprost—Eye pain—Doxorubicin—stomach cancer	0.00232	0.00262	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—KISS1R—stomach cancer	0.00231	0.0254	CbGpPWpGaD
Latanoprost—Oedema—Fluorouracil—stomach cancer	0.00228	0.00258	CcSEcCtD
Latanoprost—Connective tissue disorder—Docetaxel—stomach cancer	0.00228	0.00258	CcSEcCtD
Latanoprost—Diplopia—Epirubicin—stomach cancer	0.00226	0.00256	CcSEcCtD
Latanoprost—Nervous system disorder—Fluorouracil—stomach cancer	0.00224	0.00253	CcSEcCtD
Latanoprost—Connective tissue disorder—Capecitabine—stomach cancer	0.00221	0.0025	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.00218	0.00246	CcSEcCtD
Latanoprost—Dyspnoea—Irinotecan—stomach cancer	0.00213	0.0024	CcSEcCtD
Latanoprost—Diplopia—Doxorubicin—stomach cancer	0.00209	0.00237	CcSEcCtD
Latanoprost—Mediastinal disorder—Docetaxel—stomach cancer	0.00209	0.00237	CcSEcCtD
Latanoprost—Asthma—Methotrexate—stomach cancer	0.00209	0.00236	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.00208	0.00235	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1R—stomach cancer	0.00207	0.0227	CbGpPWpGaD
Latanoprost—Pain—Irinotecan—stomach cancer	0.00204	0.00231	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.00204	0.0023	CcSEcCtD
Latanoprost—Dyspnoea—Fluorouracil—stomach cancer	0.00204	0.0023	CcSEcCtD
Latanoprost—Mediastinal disorder—Capecitabine—stomach cancer	0.00202	0.00229	CcSEcCtD
Latanoprost—Erythema—Docetaxel—stomach cancer	0.00202	0.00228	CcSEcCtD
Latanoprost—Erythema—Capecitabine—stomach cancer	0.00195	0.00221	CcSEcCtD
Latanoprost—Asthma—Epirubicin—stomach cancer	0.00195	0.00221	CcSEcCtD
Latanoprost—Back pain—Docetaxel—stomach cancer	0.00195	0.00221	CcSEcCtD
Latanoprost—Pain—Fluorouracil—stomach cancer	0.00195	0.00221	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Methotrexate—stomach cancer	0.00194	0.0022	CcSEcCtD
Latanoprost—Angina pectoris—Epirubicin—stomach cancer	0.0019	0.00215	CcSEcCtD
Latanoprost—Back pain—Capecitabine—stomach cancer	0.00189	0.00214	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.00188	0.00213	CcSEcCtD
Latanoprost—Bronchitis—Epirubicin—stomach cancer	0.00188	0.00213	CcSEcCtD
Latanoprost—Vision blurred—Capecitabine—stomach cancer	0.00184	0.00208	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Epirubicin—stomach cancer	0.00182	0.00206	CcSEcCtD
Latanoprost—Conjunctivitis—Methotrexate—stomach cancer	0.00181	0.00205	CcSEcCtD
Latanoprost—Asthma—Doxorubicin—stomach cancer	0.00181	0.00205	CcSEcCtD
Latanoprost—Angina pectoris—Doxorubicin—stomach cancer	0.00176	0.00199	CcSEcCtD
Latanoprost—Bronchitis—Doxorubicin—stomach cancer	0.00174	0.00197	CcSEcCtD
Latanoprost—Chest pain—Docetaxel—stomach cancer	0.00172	0.00194	CcSEcCtD
Latanoprost—Arthralgia—Docetaxel—stomach cancer	0.00172	0.00194	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00171	0.00193	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Other—F2R—stomach cancer	0.00171	0.0187	CbGpPWpGaD
Latanoprost—Urinary tract infection—Epirubicin—stomach cancer	0.00169	0.00192	CcSEcCtD
Latanoprost—Conjunctivitis—Epirubicin—stomach cancer	0.00169	0.00192	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.00168	0.0019	CcSEcCtD
Latanoprost—Arthralgia—Capecitabine—stomach cancer	0.00166	0.00188	CcSEcCtD
Latanoprost—Chest pain—Capecitabine—stomach cancer	0.00166	0.00188	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00165	0.00187	CcSEcCtD
Latanoprost—Oedema—Docetaxel—stomach cancer	0.00165	0.00186	CcSEcCtD
Latanoprost—Discomfort—Capecitabine—stomach cancer	0.00164	0.00186	CcSEcCtD
Latanoprost—Nervous system disorder—Docetaxel—stomach cancer	0.00162	0.00183	CcSEcCtD
Latanoprost—Pruritus—Fluorouracil—stomach cancer	0.00162	0.00183	CcSEcCtD
Latanoprost—Skin disorder—Docetaxel—stomach cancer	0.0016	0.00181	CcSEcCtD
Latanoprost—Oedema—Capecitabine—stomach cancer	0.0016	0.00181	CcSEcCtD
Latanoprost—Dizziness—Irinotecan—stomach cancer	0.00158	0.00178	CcSEcCtD
Latanoprost—Urinary tract infection—Doxorubicin—stomach cancer	0.00157	0.00177	CcSEcCtD
Latanoprost—Conjunctivitis—Doxorubicin—stomach cancer	0.00157	0.00177	CcSEcCtD
Latanoprost—Nervous system disorder—Capecitabine—stomach cancer	0.00156	0.00177	CcSEcCtD
Latanoprost—Skin disorder—Capecitabine—stomach cancer	0.00155	0.00175	CcSEcCtD
Latanoprost—Connective tissue disorder—Epirubicin—stomach cancer	0.00154	0.00174	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—KISS1R—stomach cancer	0.00153	0.0168	CbGpPWpGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—stomach cancer	0.00152	0.0167	CbGpPWpGaD
Latanoprost—Dizziness—Fluorouracil—stomach cancer	0.00151	0.00171	CcSEcCtD
Latanoprost—Mediastinal disorder—Methotrexate—stomach cancer	0.00151	0.0017	CcSEcCtD
Latanoprost—Rash—Irinotecan—stomach cancer	0.0015	0.0017	CcSEcCtD
Latanoprost—Dermatitis—Irinotecan—stomach cancer	0.0015	0.0017	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.0015	0.0017	CcSEcCtD
Latanoprost—Headache—Irinotecan—stomach cancer	0.00149	0.00169	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—KISS1—stomach cancer	0.00149	0.0163	CbGpPWpGaD
Latanoprost—Dyspnoea—Docetaxel—stomach cancer	0.00147	0.00166	CcSEcCtD
Latanoprost—Erythema—Methotrexate—stomach cancer	0.00146	0.00165	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00145	0.00164	CcSEcCtD
Latanoprost—Rash—Fluorouracil—stomach cancer	0.00144	0.00163	CcSEcCtD
Latanoprost—Dermatitis—Fluorouracil—stomach cancer	0.00144	0.00163	CcSEcCtD
Latanoprost—Headache—Fluorouracil—stomach cancer	0.00143	0.00162	CcSEcCtD
Latanoprost—Connective tissue disorder—Doxorubicin—stomach cancer	0.00142	0.00161	CcSEcCtD
Latanoprost—Dyspnoea—Capecitabine—stomach cancer	0.00142	0.00161	CcSEcCtD
Latanoprost—Mediastinal disorder—Epirubicin—stomach cancer	0.00141	0.0016	CcSEcCtD
Latanoprost—Pain—Docetaxel—stomach cancer	0.00141	0.00159	CcSEcCtD
Latanoprost—Back pain—Methotrexate—stomach cancer	0.00141	0.00159	CcSEcCtD
Latanoprost—Vision blurred—Methotrexate—stomach cancer	0.00137	0.00155	CcSEcCtD
Latanoprost—Pain—Capecitabine—stomach cancer	0.00136	0.00154	CcSEcCtD
Latanoprost—Erythema—Epirubicin—stomach cancer	0.00136	0.00154	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—stomach cancer	0.00133	0.0146	CbGpPWpGaD
Latanoprost—Back pain—Epirubicin—stomach cancer	0.00132	0.00149	CcSEcCtD
Latanoprost—Mediastinal disorder—Doxorubicin—stomach cancer	0.0013	0.00148	CcSEcCtD
Latanoprost—Vision blurred—Epirubicin—stomach cancer	0.00128	0.00145	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—GAST—stomach cancer	0.00128	0.0141	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—RGS2—stomach cancer	0.00128	0.0141	CbGpPWpGaD
Latanoprost—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—stomach cancer	0.00127	0.0139	CbGpPWpGaD
Latanoprost—Erythema—Doxorubicin—stomach cancer	0.00126	0.00143	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Other—ADRB2—stomach cancer	0.00126	0.0138	CbGpPWpGaD
Latanoprost—Chest pain—Methotrexate—stomach cancer	0.00124	0.0014	CcSEcCtD
Latanoprost—Arthralgia—Methotrexate—stomach cancer	0.00124	0.0014	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00123	0.00139	CcSEcCtD
Latanoprost—Discomfort—Methotrexate—stomach cancer	0.00122	0.00138	CcSEcCtD
Latanoprost—Back pain—Doxorubicin—stomach cancer	0.00122	0.00138	CcSEcCtD
Latanoprost—Vision blurred—Doxorubicin—stomach cancer	0.00119	0.00134	CcSEcCtD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.00118	0.0129	CbGpPWpGaD
Latanoprost—Pruritus—Docetaxel—stomach cancer	0.00117	0.00132	CcSEcCtD
Latanoprost—Nervous system disorder—Methotrexate—stomach cancer	0.00116	0.00132	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—KISS1R—stomach cancer	0.00116	0.0128	CbGpPWpGaD
Latanoprost—Arthralgia—Epirubicin—stomach cancer	0.00116	0.00131	CcSEcCtD
Latanoprost—Chest pain—Epirubicin—stomach cancer	0.00116	0.00131	CcSEcCtD
Latanoprost—SLC22A1—Neurotransmitter Release Cycle—HSPA8—stomach cancer	0.00116	0.0127	CbGpPWpGaD
Latanoprost—Skin disorder—Methotrexate—stomach cancer	0.00115	0.00131	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00115	0.0013	CcSEcCtD
Latanoprost—Discomfort—Epirubicin—stomach cancer	0.00115	0.0013	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—RGS2—stomach cancer	0.00114	0.0126	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—stomach cancer	0.00114	0.0126	CbGpPWpGaD
Latanoprost—Pruritus—Capecitabine—stomach cancer	0.00113	0.00128	CcSEcCtD
Latanoprost—Oedema—Epirubicin—stomach cancer	0.00111	0.00126	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	0.00111	0.0121	CbGpPWpGaD
Latanoprost—Nervous system disorder—Epirubicin—stomach cancer	0.00109	0.00123	CcSEcCtD
Latanoprost—Dizziness—Docetaxel—stomach cancer	0.00109	0.00123	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00108	0.00122	CcSEcCtD
Latanoprost—Skin disorder—Epirubicin—stomach cancer	0.00108	0.00122	CcSEcCtD
Latanoprost—Chest pain—Doxorubicin—stomach cancer	0.00107	0.00121	CcSEcCtD
Latanoprost—Arthralgia—Doxorubicin—stomach cancer	0.00107	0.00121	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00107	0.00121	CcSEcCtD
Latanoprost—Discomfort—Doxorubicin—stomach cancer	0.00106	0.0012	CcSEcCtD
Latanoprost—Dyspnoea—Methotrexate—stomach cancer	0.00106	0.0012	CcSEcCtD
Latanoprost—Dizziness—Capecitabine—stomach cancer	0.00105	0.00119	CcSEcCtD
Latanoprost—Rash—Docetaxel—stomach cancer	0.00104	0.00118	CcSEcCtD
Latanoprost—Dermatitis—Docetaxel—stomach cancer	0.00104	0.00117	CcSEcCtD
Latanoprost—Headache—Docetaxel—stomach cancer	0.00103	0.00117	CcSEcCtD
Latanoprost—Oedema—Doxorubicin—stomach cancer	0.00103	0.00116	CcSEcCtD
Latanoprost—Pain—Methotrexate—stomach cancer	0.00102	0.00115	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.00101	0.00115	CcSEcCtD
Latanoprost—Nervous system disorder—Doxorubicin—stomach cancer	0.00101	0.00114	CcSEcCtD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.00101	0.0111	CbGpPWpGaD
Latanoprost—Rash—Capecitabine—stomach cancer	0.00101	0.00114	CcSEcCtD
Latanoprost—Dermatitis—Capecitabine—stomach cancer	0.001	0.00114	CcSEcCtD
Latanoprost—Headache—Capecitabine—stomach cancer	0.000999	0.00113	CcSEcCtD
Latanoprost—Skin disorder—Doxorubicin—stomach cancer	0.000999	0.00113	CcSEcCtD
Latanoprost—Dyspnoea—Epirubicin—stomach cancer	0.000991	0.00112	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	0.000986	0.0108	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—F2R—stomach cancer	0.000959	0.0105	CbGpPWpGaD
Latanoprost—Pain—Epirubicin—stomach cancer	0.00095	0.00108	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000937	0.00106	CcSEcCtD
Latanoprost—Dyspnoea—Doxorubicin—stomach cancer	0.000917	0.00104	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—ANXA1—stomach cancer	0.000902	0.0099	CbGpPWpGaD
Latanoprost—Pain—Doxorubicin—stomach cancer	0.000879	0.000995	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2R—stomach cancer	0.000858	0.00942	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—HRH4—stomach cancer	0.000842	0.00925	CbGpPWpGaD
Latanoprost—Pruritus—Methotrexate—stomach cancer	0.00084	0.000951	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—stomach cancer	0.000806	0.00886	CbGpPWpGaD
Latanoprost—Pruritus—Epirubicin—stomach cancer	0.000786	0.00089	CcSEcCtD
Latanoprost—Dizziness—Methotrexate—stomach cancer	0.000785	0.000889	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—KISS1—stomach cancer	0.000751	0.00824	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.00075	0.00823	CbGpPWpGaD
Latanoprost—Rash—Methotrexate—stomach cancer	0.000749	0.000847	CcSEcCtD
Latanoprost—Dermatitis—Methotrexate—stomach cancer	0.000748	0.000847	CcSEcCtD
Latanoprost—Headache—Methotrexate—stomach cancer	0.000744	0.000842	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.000741	0.00814	CbGpPWpGaD
Latanoprost—Dizziness—Epirubicin—stomach cancer	0.000735	0.000832	CcSEcCtD
Latanoprost—Pruritus—Doxorubicin—stomach cancer	0.000728	0.000823	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.000722	0.00793	CbGpPWpGaD
Latanoprost—Rash—Epirubicin—stomach cancer	0.000701	0.000793	CcSEcCtD
Latanoprost—Dermatitis—Epirubicin—stomach cancer	0.0007	0.000792	CcSEcCtD
Latanoprost—Headache—Epirubicin—stomach cancer	0.000696	0.000788	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HBEGF—stomach cancer	0.000686	0.00753	CbGpPWpGaD
Latanoprost—Dizziness—Doxorubicin—stomach cancer	0.00068	0.000769	CcSEcCtD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.000675	0.00741	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—KISS1R—stomach cancer	0.000658	0.00723	CbGpPWpGaD
Latanoprost—Rash—Doxorubicin—stomach cancer	0.000648	0.000734	CcSEcCtD
Latanoprost—Dermatitis—Doxorubicin—stomach cancer	0.000648	0.000733	CcSEcCtD
Latanoprost—Headache—Doxorubicin—stomach cancer	0.000644	0.000729	CcSEcCtD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.000642	0.00706	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.000635	0.00698	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.000618	0.00679	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KISS1R—stomach cancer	0.000598	0.00657	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.000597	0.00656	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000578	0.00635	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—SLC1A2—stomach cancer	0.000557	0.00611	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000547	0.00601	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000527	0.00579	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000512	0.00562	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—AGTR2—stomach cancer	0.000489	0.00537	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—F2R—stomach cancer	0.000484	0.00531	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—HRH4—stomach cancer	0.000476	0.00523	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—HTR1A—stomach cancer	0.000471	0.00517	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000469	0.00515	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—ANXA1—stomach cancer	0.000455	0.00499	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000451	0.00496	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—ADRB1—stomach cancer	0.00044	0.00484	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HRH4—stomach cancer	0.000432	0.00475	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000432	0.00474	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—SLC1A2—stomach cancer	0.000426	0.00468	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—KISS1—stomach cancer	0.000424	0.00466	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000385	0.00423	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KISS1—stomach cancer	0.000385	0.00423	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—RGS2—stomach cancer	0.000365	0.00401	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GAST—stomach cancer	0.000365	0.00401	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—ADRB2—stomach cancer	0.000357	0.00392	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GLI3—stomach cancer	0.000353	0.00388	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KISS1R—stomach cancer	0.000353	0.00388	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RBP1—stomach cancer	0.000337	0.0037	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—HSPA8—stomach cancer	0.000333	0.00365	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—RGS2—stomach cancer	0.000331	0.00364	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GAST—stomach cancer	0.000331	0.00364	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AGTR2—stomach cancer	0.000276	0.00304	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—WWOX—stomach cancer	0.000275	0.00302	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—F2R—stomach cancer	0.000273	0.003	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000272	0.00299	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—HTR1A—stomach cancer	0.000266	0.00292	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ANXA1—stomach cancer	0.000257	0.00282	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HRH4—stomach cancer	0.000255	0.0028	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—WIF1—stomach cancer	0.000255	0.0028	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—HSPA8—stomach cancer	0.000255	0.0028	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AGTR2—stomach cancer	0.000251	0.00276	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ADRB1—stomach cancer	0.000249	0.00273	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—F2R—stomach cancer	0.000248	0.00273	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ACAD8—stomach cancer	0.000247	0.00271	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HTR1A—stomach cancer	0.000242	0.00265	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKAB1—stomach cancer	0.000236	0.00259	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000235	0.00258	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ANXA1—stomach cancer	0.000233	0.00256	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000231	0.00253	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000229	0.00252	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KISS1—stomach cancer	0.000228	0.0025	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RNF43—stomach cancer	0.000228	0.0025	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000226	0.00249	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ADRB1—stomach cancer	0.000226	0.00248	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000223	0.00245	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000223	0.00245	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GMPR2—stomach cancer	0.00022	0.00242	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—PIK3CA—stomach cancer	0.000217	0.00238	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000211	0.00232	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FST—stomach cancer	0.000203	0.00223	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ADRB2—stomach cancer	0.000202	0.00221	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SUCLG1—stomach cancer	0.000201	0.00221	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—IDH3B—stomach cancer	0.000201	0.00221	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HBEGF—stomach cancer	0.000198	0.00218	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GAST—stomach cancer	0.000196	0.00215	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RGS2—stomach cancer	0.000196	0.00215	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	0.000194	0.00213	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NDUFV1—stomach cancer	0.000187	0.00205	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NDUFS1—stomach cancer	0.000187	0.00205	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGG—stomach cancer	0.000185	0.00204	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ADRB2—stomach cancer	0.000183	0.00201	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.000181	0.00199	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PPP2R1A—stomach cancer	0.000179	0.00197	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	0.000179	0.00197	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKAA1—stomach cancer	0.000179	0.00196	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000175	0.00192	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RBP4—stomach cancer	0.000172	0.00189	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCL8—stomach cancer	0.000172	0.00189	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	0.000172	0.00189	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PGLS—stomach cancer	0.000167	0.00183	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—BLVRB—stomach cancer	0.000167	0.00183	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPAP2A—stomach cancer	0.000159	0.00175	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HSPB1—stomach cancer	0.000148	0.00163	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AGTR2—stomach cancer	0.000148	0.00163	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—F2R—stomach cancer	0.000147	0.00161	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BMP2—stomach cancer	0.000147	0.00161	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKR1C3—stomach cancer	0.000144	0.00158	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HTR1A—stomach cancer	0.000143	0.00157	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—FBP1—stomach cancer	0.000142	0.00156	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NDUFA2—stomach cancer	0.000142	0.00156	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CKB—stomach cancer	0.000142	0.00156	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CA1—stomach cancer	0.000142	0.00156	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—PRKCB—stomach cancer	0.000139	0.00153	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ALB—stomach cancer	0.000138	0.00152	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PRKCB—stomach cancer	0.000138	0.00152	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ANXA1—stomach cancer	0.000138	0.00151	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADRB1—stomach cancer	0.000134	0.00147	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLIN2—stomach cancer	0.000133	0.00146	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CA2—stomach cancer	0.00013	0.00142	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RPS6—stomach cancer	0.000128	0.0014	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PGAM1—stomach cancer	0.000126	0.00139	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NT5E—stomach cancer	0.000126	0.00139	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PRKCB—stomach cancer	0.000125	0.00138	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6ST—stomach cancer	0.000125	0.00137	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000122	0.00134	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PLCE1—stomach cancer	0.00012	0.00132	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDH7A1—stomach cancer	0.00012	0.00132	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HBEGF—stomach cancer	0.000117	0.00129	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UMPS—stomach cancer	0.000116	0.00127	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6R—stomach cancer	0.000112	0.00123	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—RHOA—stomach cancer	0.000111	0.00122	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADRB2—stomach cancer	0.000108	0.00119	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PDHA1—stomach cancer	0.000107	0.00118	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ECHS1—stomach cancer	0.000107	0.00118	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PPP2R1A—stomach cancer	0.000106	0.00116	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000103	0.00114	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—FADS1—stomach cancer	0.000101	0.00111	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TYMP—stomach cancer	0.000101	0.00111	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—RHOA—stomach cancer	0.000101	0.00111	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SMAD4—stomach cancer	9.84e-05	0.00108	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL8—stomach cancer	9.74e-05	0.00107	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SREBF2—stomach cancer	9.45e-05	0.00104	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FYN—stomach cancer	9.34e-05	0.00103	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—MAPK1—stomach cancer	9.34e-05	0.00103	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—RORA—stomach cancer	9.34e-05	0.00103	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL8—stomach cancer	8.84e-05	0.000971	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGFR2—stomach cancer	8.77e-05	0.000964	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDOB—stomach cancer	8.75e-05	0.000962	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALOX5—stomach cancer	8.14e-05	0.000894	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IRS2—stomach cancer	8.03e-05	0.000882	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—DPYD—stomach cancer	8.01e-05	0.000879	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—APOA1—stomach cancer	7.83e-05	0.00086	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CAV1—stomach cancer	7.79e-05	0.000856	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOA1—stomach cancer	7.77e-05	0.000854	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—HRAS—stomach cancer	7.5e-05	0.000824	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKCB—stomach cancer	7.41e-05	0.000814	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6ST—stomach cancer	7.38e-05	0.000811	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—MAPK1—stomach cancer	7.16e-05	0.000786	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APC—stomach cancer	7.09e-05	0.000779	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTT1—stomach cancer	7.08e-05	0.000778	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2A6—stomach cancer	7e-05	0.000769	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKR1C3—stomach cancer	6.81e-05	0.000748	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MAPK3—stomach cancer	6.79e-05	0.000746	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ENO1—stomach cancer	6.63e-05	0.000729	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6R—stomach cancer	6.59e-05	0.000724	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MAPK1—stomach cancer	6.47e-05	0.00071	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EGFR—stomach cancer	6.46e-05	0.00071	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ALB—stomach cancer	6.2e-05	0.000682	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CA—stomach cancer	6.18e-05	0.000679	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SERPINE1—stomach cancer	6.17e-05	0.000678	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KRAS—stomach cancer	6.11e-05	0.000671	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RHOA—stomach cancer	5.95e-05	0.000654	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOS3—stomach cancer	5.89e-05	0.000647	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CD44—stomach cancer	5.88e-05	0.000646	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—HRAS—stomach cancer	5.75e-05	0.000631	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CA—stomach cancer	5.61e-05	0.000616	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB2—stomach cancer	5.51e-05	0.000605	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL8—stomach cancer	5.22e-05	0.000574	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HRAS—stomach cancer	5.19e-05	0.00057	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1B—stomach cancer	5.1e-05	0.00056	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPP2R1A—stomach cancer	5e-05	0.00055	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—stomach cancer	4.97e-05	0.000546	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTP1—stomach cancer	4.91e-05	0.000539	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCND1—stomach cancer	4.87e-05	0.000535	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JUN—stomach cancer	4.86e-05	0.000533	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMOX1—stomach cancer	4.84e-05	0.000532	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—stomach cancer	4.73e-05	0.000519	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1A—stomach cancer	4.71e-05	0.000517	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK8—stomach cancer	4.6e-05	0.000505	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TYMS—stomach cancer	4.56e-05	0.000501	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM1—stomach cancer	4.51e-05	0.000495	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—stomach cancer	4.24e-05	0.000466	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ERCC2—stomach cancer	4.24e-05	0.000466	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT3—stomach cancer	4.2e-05	0.000461	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK3—stomach cancer	4.01e-05	0.000441	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTHFR—stomach cancer	3.99e-05	0.000438	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MYC—stomach cancer	3.9e-05	0.000429	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK1—stomach cancer	3.82e-05	0.00042	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGFR—stomach cancer	3.82e-05	0.000419	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CAV1—stomach cancer	3.68e-05	0.000404	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOA1—stomach cancer	3.67e-05	0.000403	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KRAS—stomach cancer	3.61e-05	0.000396	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CA—stomach cancer	3.31e-05	0.000364	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARG—stomach cancer	3.23e-05	0.000355	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—stomach cancer	3.21e-05	0.000352	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HRAS—stomach cancer	3.07e-05	0.000337	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—stomach cancer	2.93e-05	0.000322	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALB—stomach cancer	2.91e-05	0.000319	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NOS3—stomach cancer	2.78e-05	0.000305	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS2—stomach cancer	2.54e-05	0.000279	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CA—stomach cancer	1.56e-05	0.000172	CbGpPWpGaD
